Cargando…

The Slow-Releasing Hydrogen Sulfide Donor, GYY4137, Exhibits Novel Anti-Cancer Effects In Vitro and In Vivo

The slow-releasing hydrogen sulfide (H(2)S) donor, GYY4137, caused concentration-dependent killing of seven different human cancer cell lines (HeLa, HCT-116, Hep G2, HL-60, MCF-7, MV4-11 and U2OS) but did not affect survival of normal human lung fibroblasts (IMR90, WI-38) as determined by trypan blu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Zheng Wei, Zhou, Jianbiao, Chen, Chien-Shing, Zhao, Yujun, Tan, Choon-Hong, Li, Ling, Moore, Philip Keith, Deng, Lih-Wen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3119065/ https://www.ncbi.nlm.nih.gov/pubmed/21701688 http://dx.doi.org/10.1371/journal.pone.0021077

Ejemplares similares

Hydrogen Sulfide Donor GYY4137 Protects against Myocardial Fibrosis
por: Meng, Guoliang, et al.
Publicado: (2015)

The complex effects of the slow-releasing hydrogen sulfide donor GYY4137 in a model of acute joint inflammation and in human cartilage cells
por: Li, Ling, et al.
Publicado: (2013)

Synthesis of Sulfur-35-Labeled Trisulfides and GYY-4137 as Donors of Radioactive Hydrogen Sulfide
por: Brown, Eric M., et al.
Publicado: (2023)

Improved growth of pea, lettuce, and radish plants using the slow release of hydrogen sulfide from GYY-4137
por: Carter, Justin M., et al.
Publicado: (2018)

Hydrogen Sulfide Donor GYY4137 Rescues NRF2 Activation in Respiratory Syncytial Virus Infection
por: de Mello, Aline Haas, et al.
Publicado: (2022)

GYY4137, a Hydrogen Sulfide Donor Modulates miR194-Dependent Collagen Realignment in Diabetic Kidney
por: John, AM Sashi Papu, et al.
Publicado: (2017)

Vasoactive Effects of Chronic Treatment with Fructose and Slow-Releasing H(2)S Donor GYY-4137 in Spontaneously Hypertensive Rats: The Role of Nitroso and Sulfide Signalization
por: Berenyiova, Andrea, et al.
Publicado: (2022)

Upregulation of Tolerogenic Pathways by the Hydrogen Sulfide Donor GYY4137 and Impaired Expression of H(2)S-Producing Enzymes in Multiple Sclerosis
por: Lazarević, Milica, et al.
Publicado: (2020)

GYY4137-Derived Hydrogen Sulfide Donates Electrons to the Mitochondrial Electron Transport Chain via Sulfide: Quinone Oxidoreductase in Endothelial Cells
por: Star, Bastiaan S., et al.
Publicado: (2023)

GYY4137, an H(2)S Slow-Releasing Donor, Prevents Nitrative Stress and α-Synuclein Nitration in an MPTP Mouse Model of Parkinson’s Disease
por: Hou, Xiaoou, et al.
Publicado: (2017)

A H(2)S Donor GYY4137 Exacerbates Cisplatin-Induced Nephrotoxicity in Mice
por: Liu, Mi, et al.
Publicado: (2016)

Hydrogen sulfide donor GYY4137 suppresses proliferation of human colorectal cancer Caco-2 cells by inducing both cell cycle arrest and cell death
por: Sakuma, Satoru, et al.
Publicado: (2019)

The H(2)S-Releasing Naproxen Derivative ATB-346 and the Slow-Release H(2)S Donor GYY4137 Reduce Intestinal Inflammation and Restore Transit in Postoperative Ileus
por: Van Dingenen, Jonas, et al.
Publicado: (2019)

GYY4137 and Sodium Hydrogen Sulfide Relaxations Are Inhibited by L-Cysteine and K(V)7 Channel Blockers in Rat Small Mesenteric Arteries
por: Abramavicius, Silvijus, et al.
Publicado: (2021)

Experimental research into the potential therapeutic effect of GYY4137 on Ovariectomy-induced osteoporosis
por: Xu, Zhong-Shi, et al.
Publicado: (2018)

GYY4137 Attenuates Sodium Deoxycholate-Induced Intestinal Barrier Injury Both In Vitro and In Vivo
por: Chen, Zeyang, et al.
Publicado: (2019)

A New Slow Releasing, H(2)S Generating Compound, GYY4137 Relaxes Spontaneous and Oxytocin-Stimulated Contractions of Human and Rat Pregnant Myometrium
por: Robinson, Hayley, et al.
Publicado: (2012)

The protective effects of GYY4137 on ipsilateral testicular injury in experimentally varicocele-induced rats
por: Ning, Jin-Zhuo, et al.
Publicado: (2018)

The Anxiolytic and Antidepressant Effects of Diallyl Disulfide and GYY4137 in Animals with Chronic Neuropathic Pain
por: Bai, Xue, et al.
Publicado: (2021)

GYY4137 protects against myocardial ischemia and reperfusion injury by attenuating oxidative stress and apoptosis in rats
por: Meng, Guoliang, et al.
Publicado: (2015)

GYY4137 Promotes Mice Feeding Behavior via Arcuate Nucleus Sulfur-Sulfhydrylation and AMPK Activation
por: Zhou, Jun, et al.
Publicado: (2018)

GYY4137 Regulates Extracellular Matrix Turnover in the Diabetic Kidney by Modulating Retinoid X Receptor Signaling
por: Juin, Subir Kumar, et al.
Publicado: (2021)

TRPA1 Ion Channel Determines Beneficial and Detrimental Effects of GYY4137 in Murine Serum-Transfer Arthritis
por: Bátai, István Z., et al.
Publicado: (2019)

Increased circulating peroxiredoxin-4 in sepsis model rats involves secretion from hepatocytes and is mitigated by GYY4137
por: Unuma, Kana, et al.
Publicado: (2019)

The H(2)S Donor GYY4137 Stimulates Reactive Oxygen Species Generation in BV2 Cells While Suppressing the Secretion of TNF and Nitric Oxide
por: Lazarević, Milica, et al.
Publicado: (2018)

Characterization of the Inducible and Slow-Releasing Hydrogen Sulfide and Persulfide Donor P*: Insights into Hydrogen Sulfide Signaling
por: Trummer, Modesta, et al.
Publicado: (2021)

GYY4137 a H(2)S donor, attenuates ipsilateral epididymis injury in experimentally varicocele-induced rats via activation of the PI3K/Akt pathway
por: Xia, Yu-qi, et al.
Publicado: (2019)

A Long-Term and Slow-Releasing Hydrogen Sulfide Donor Protects against Myocardial Ischemia/Reperfusion Injury
por: Sun, Xiaotian, et al.
Publicado: (2017)

Hydrogen Sulfide in Pharmacotherapy, Beyond the Hydrogen Sulfide-Donors
por: Zaorska, Ewelina, et al.
Publicado: (2020)

Glutathione-Garlic Sulfur Conjugates: Slow Hydrogen Sulfide Releasing Agents for Therapeutic Applications
por: Bhuiyan, Ashif Iqbal, et al.
Publicado: (2015)

The Inhibitory Effects of Slow-Releasing Hydrogen Sulfide Donors in the Mechanical Allodynia, Grip Strength Deficits, and Depressive-Like Behaviors Associated with Chronic Osteoarthritis Pain
por: Batallé, Gerard, et al.
Publicado: (2019)

Neuroprotective effects of ammonium tetrathiomolybdate, a slow-release sulfide donor, in a rodent model of regional stroke
por: Mendonça, Bruna Pescador, et al.
Publicado: (2020)

ADT-OH, a hydrogen sulfide-releasing donor, induces apoptosis and inhibits the development of melanoma in vivo by upregulating FADD
por: Cai, Fangfang, et al.
Publicado: (2020)

Role of hydrogen sulfide donors in cancer development and progression
por: Ngowi, Ebenezeri Erasto, et al.
Publicado: (2021)

Roles of Hydrogen Sulfide Donors in Common Kidney Diseases
por: Ngowi, Ebenezeri Erasto, et al.
Publicado: (2020)

The Potential of Hydrogen Sulfide Donors in Treating Cardiovascular Diseases
por: Wang, Yi-Zhen, et al.
Publicado: (2021)

The Effect of a Fast-Releasing Hydrogen Sulfide Donor on Vascularization of Subcutaneous Scaffolds in Immunocompetent and Immunocompromised Mice
por: Smink, Alexandra M., et al.
Publicado: (2020)

The Recovery of Cognitive and Affective Deficiencies Linked with Chronic Osteoarthritis Pain and Implicated Pathways by Slow-Releasing Hydrogen Sulfide Treatment
por: Batallé, Gerard, et al.
Publicado: (2021)

Understanding Hydrogen Sulfide Storage: Probing Conditions for Sulfide Release from Hydrodisulfides
por: Bailey, T. Spencer, et al.
Publicado: (2014)

Synthesis, Stability, and Kinetics of Hydrogen Sulfide Release of Dithiophosphates
por: Brown, Eric M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1b3rv3fde0l61qkvr6f80gli00